Both in Pharmaceuticals
Bicycle Therapeutics vs Mereo BioPharma Group
Over the past year BCYC returned −43.5% and MREO returned −83.1%; their daily moves had a correlation of 0.09.
BCYC −43.5% MREO −83.1%Growth of $1, one year, split-adjusted
| Metric | BCYC | MREO |
|---|---|---|
| Price | $3.72 | $0.2999 |
| Market cap | $260.4M | $47.9M |
| Today | −1.46% | +1.63% |
| 1 month | −2.2% | −4.9% |
| 6 months | −21.3% | +21.9% |
| Year to date | −47.5% | −28.0% |
| 1 year | −42.3% | −83.3% |
| Revenue growth (YoY) | +190.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −30.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $469.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 57.1% | 78.8% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).